TBOPP (0.67 mg per mouse; administrated on days 0, 1, 3, and 5; for 2 weeks; C57BL/6 mice) treatment effectively suppresses metastasis of cancer cells in vivo and the number of lymphocytes in the spleen is not changed, the body weight is also unchanged between TBOPP-treated and non-treated mice[1].
| Animal Model: | C57BL/6 mice (6- to 8-week-old) with ex-3LL cells[1] |
| Dosage: | 0.67 mg per mouse |
| Administration: | Administrated on days 0, 1, 3, and 5; for 2 weeks |
| Result: | The lung metastasis was significantly suppressed.
|
